Technical Analysis for TLOG - Tetralogic Pharmaceu

Grade Last Price % Change Price Change
grade C 0.041 -0.24% -0.0001
TLOG closed down 0.24 percent on Thursday, October 17, 2019, on 7 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical TLOG trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -0.24%
Inside Day Range Contraction -0.24%
Wide Bands Range Expansion -0.24%
Oversold Stochastic Weakness -0.24%
20 DMA Resistance Bearish -0.24%
180 Bearish Setup Bearish Swing Setup -0.24%

Older signals for TLOG ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.
Biopharmaceutical Life Sciences Organ Systems Infectious Diseases Autoimmune Diseases Alopecia Areata Apoptosis Cutaneous T Cell Lymphoma Histone Deacetylase Small Molecule Therapies
Is TLOG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.1
52 Week Low 0.0015
Average Volume 15,834
200-Day Moving Average 0.0365
50-Day Moving Average 0.0684
20-Day Moving Average 0.0577
10-Day Moving Average 0.0508
Average True Range 0.013
ADX 13.4
+DI 22.9121
-DI 27.3077
Chandelier Exit (Long, 3 ATRs ) 0.04899999999999999
Chandelier Exit (Short, 3 ATRs ) 0.0785
Upper Bollinger Band 0.078
Lower Bollinger Band 0.0374
Percent B (%b) 0.09
BandWidth 70.363952
MACD Line -0.0071
MACD Signal Line -0.0053
MACD Histogram -0.0017
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0410
Resistance 3 (R3) 0.0410 0.0410 0.0410
Resistance 2 (R2) 0.0410 0.0410 0.0410 0.0410
Resistance 1 (R1) 0.0410 0.0410 0.0410 0.0410 0.0410
Pivot Point 0.0410 0.0410 0.0410 0.0410 0.0410
Support 1 (S1) 0.0410 0.0410 0.0410 0.0410 0.0410
Support 2 (S2) 0.0410 0.0410 0.0410 0.0410
Support 3 (S3) 0.0410 0.0410 0.0410
Support 4 (S4) 0.0410